Menu Search
Equities

Chemometec A/S

CHY:BER

Chemometec A/S

Actions
  • Price (EUR)52.15
  • Today's Change1.50 / 2.96%
  • Shares traded--
  • 1 Year change+11.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Chemometec A/S's revenues fell -8.22%from 444.40m to 407.87m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a -23.72% reduction in net income from 178.67m to 136.28m.
Gross margin78.80%
Net profit margin33.41%
Operating margin41.43%
Return on assets20.42%
Return on equity24.82%
Return on investment24.40%
More ▼

Cash flow in DKKView more

In 2024, cash reserves at Chemometec A/S fell by 20.43m. However, the company earned 129.00m from its operations for a Cash Flow Margin of 31.63%. In addition the company used 43.49m on investing activities and also paid 105.72m in financing cash flows.
Cash flow per share8.85
Price/Cash flow per share54.74
Book value per share32.48
Tangible book value per share27.05
More ▼

Balance sheet in DKKView more

Chemometec A/S has little financial risk as the capital structure does not rely on leverage.
Current ratio4.97
Quick ratio3.76
Total debt/total equity0.0074
Total debt/total capital0.0073
More ▼

Growth rates in DKK

SmartText is unavailable
Div yield(5 year avg)0.58%
Div growth rate (5 year)-11.81%
Payout ratio (TTM)510.70%
EPS growth(5 years)23.83
EPS (TTM) vs
TTM 1 year ago		-23.73
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.